IDEXX LABORATORIES INC /DE Quarterly Operating Income (Loss) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Idexx Laboratories Inc /De quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q3 2024.
  • Idexx Laboratories Inc /De Operating Income (Loss) for the quarter ending September 30, 2024 was $304M, a 10.4% increase year-over-year.
  • Idexx Laboratories Inc /De Operating Income (Loss) for the twelve months ending September 30, 2024 was $1.11B, a 3.12% increase year-over-year.
  • Idexx Laboratories Inc /De annual Operating Income (Loss) for 2023 was $1.1B, a 22.1% increase from 2022.
  • Idexx Laboratories Inc /De annual Operating Income (Loss) for 2022 was $899M, a 3.57% decline from 2021.
  • Idexx Laboratories Inc /De annual Operating Income (Loss) for 2021 was $932M, a 34.2% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.11B $304M +$28.6M +10.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $1.08B $264M -$32.3M -10.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $1.12B $299M +$18.6M +6.62% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $1.1B $245M +$18.8M +8.29% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $1.08B $275M +$30.5M +12.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $1.05B $296M +$117M +65.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $931M $280M +$32.1M +12.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $899M $227M +$27.3M +13.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $871M $245M +$18.9M +8.35% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $853M $179M -$80.2M -30.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $933M $248M +$722K +0.29% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $932M $199M +$14.1M +7.62% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $918M $226M +$54.1M +31.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $864M $259M +$66M +34.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $798M $248M +$103M +71.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $695M $185M +$69.5M +60.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 $625M $172M +$32.1M +22.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $593M $193M +$29M +17.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $564M $144M +$11.2M +8.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $553M $116M +$284K +0.25% Oct 1, 2019 Dec 31, 2019 10-K 2020-02-14
Q3 2019 $553M $140M +$22.5M +19.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $530M $164M +$18.7M +12.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $511M $133M +$20.1M +17.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 $491M $115M +$17.5M +17.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-14
Q3 2018 $474M $117M +$16.9M +16.9% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-14
Q2 2018 $457M $146M +$23M +18.8% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-14
Q1 2018 $434M $113M +$20.8M +22.6% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-14
Q4 2017 $413M $97.8M +$14M +16.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-15
Q3 2017 $399M $100M +$12M +13.5% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-15
Q2 2017 $387M $123M +$18.4M +17.7% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-15
Q1 2017 $369M $92.2M +$18.5M +25% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-15
Q4 2016 $350M $83.8M +$16.9M +25.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-16
Q3 2016 $333M $88.5M +$16.6M +23% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-16
Q2 2016 $317M $104M +$15.9M +18% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-16
Q1 2016 $301M $73.8M +$990K +1.36% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-16
Q4 2015 $300M $66.9M +$32.1M +92.3% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-17
Q3 2015 $268M $71.9M -$294K -0.41% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-17
Q2 2015 $268M $88.3M +$5.08M +6.11% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-17
Q1 2015 $263M $72.8M +$2.76M +3.94% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-17
Q4 2014 $260M $34.8M -$26.5M -43.3% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-17
Q3 2014 $287M $72.2M +$6.7M +10.2% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-17
Q2 2014 $280M $83.2M +$4.46M +5.66% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-17
Q1 2014 $276M $70M +$8.86M +14.5% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-17
Q4 2013 $267M $61.3M -$2.1M -3.31% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-17
Q3 2013 $269M $65.5M +$2.57M +4.09% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-17
Q2 2013 $266M $78.8M +$2.95M +3.89% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-17
Q1 2013 $263M $61.2M +$781K +1.29% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-17
Q4 2012 $263M $63.4M +$8.13M +14.7% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-18
Q3 2012 $254M $62.9M +$6.82M +12.2% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-18
Q2 2012 $248M $75.8M +$4.52M +6.34% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-18
Q1 2012 $243M $60.4M +$6.88M +12.8% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-18
Q4 2011 $236M $55.3M +$4.5M +8.85% Oct 1, 2011 Dec 31, 2011 10-K 2013-02-19
Q3 2011 $232M $56.1M +$6.28M +12.6% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-19
Q2 2011 $225M $71.3M +$16.5M +30% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-19
Q1 2011 $209M $53.5M +$5.1M +10.5% Jan 1, 2011 Mar 31, 2011 10-K 2013-02-19
Q4 2010 $204M $50.8M Oct 1, 2010 Dec 31, 2010 10-K 2012-02-17
Q3 2010 $49.8M Jul 1, 2010 Sep 30, 2010 10-K 2012-02-17
Q2 2010 $54.8M Apr 1, 2010 Jun 30, 2010 10-K 2012-02-17
Q1 2010 $48.4M Jan 1, 2010 Mar 31, 2010 10-K 2012-02-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.